|
Generic:
|
|
Orlistat
|
| |
|
Therapeutic Class:
|
|
Antiobesity
|
| |
|
Composition:
|
|
Each Abnil capsule contains 120
mg orlistat.
|
| |
|
Description:
|
|
Abnil (Orlistat) is a lipase
inhibitor for obesity management.
|
| |
|
Indications:
|
|
Abnil is indicated:
- For obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet.
- To reduce the risk for weight regain after prior weight loss.
- For obese patients with an initial body mass index
 in the presence of other risk factors (eg, hypertension, diabetes, dyslipidemia).
|
| |
|
Dosage:
|
|
The recommended dose of Abnil is
one capsule three times daily with each main meal containing fat (during or
up to 1 hour after the meal).
|
| |
|
Presentation:
|
|
Abnil 120 mg capsule is available in the pack of 30’s.
|
|
|
in the presence of other risk factors (eg, hypertension, diabetes, dyslipidemia).